In this week’s edition, risk for cognitive decline is associated with older COVID-19 survivors; a study validates an FDA-approved blood test for traumatic brain injury; and more.
Read the full coverage here:
Risk for cognitive decline associated with older COVID-19 survivors
Study validates FDA-approved blood test for traumatic brain injury
VA hospital telestroke networks improve treatment, lower ED transfer rate
Lower left atrial function associated with higher risk for dementia
Rates of neurological events higher with SARS-CoV-2 infection than with COVID-19 vaccine
References:
Liu YH, et al. JAMA Neurol. 2022;doi:10.1001/jamaneurol.2022.0461.
Papa L, et al. JAMA Netw Open. 2022;doi:10.1001/jamanetworkopen.2022.1302.
Lyerly M, et al. Neurology. 2022;doi:10.1212/WNL.0000000000200143.
